IRIS
FEDERICO, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 24.163
NA - Nord America 9.555
AS - Asia 8.247
SA - Sud America 1.790
AF - Africa 130
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 4
Totale 43.913
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 15.196
US - Stati Uniti d'America 9.372
SG - Singapore 3.234
IE - Irlanda 2.400
IT - Italia 1.857
CN - Cina 1.750
BR - Brasile 1.494
HK - Hong Kong 1.412
UA - Ucraina 1.282
GB - Regno Unito 1.014
DE - Germania 597
VN - Vietnam 522
FR - Francia 433
SE - Svezia 384
FI - Finlandia 374
KR - Corea 327
TR - Turchia 281
GR - Grecia 257
JP - Giappone 195
IN - India 186
AR - Argentina 127
AT - Austria 86
NL - Olanda 76
MX - Messico 71
BD - Bangladesh 60
CA - Canada 60
PL - Polonia 59
EC - Ecuador 52
IQ - Iraq 50
ID - Indonesia 47
ZA - Sudafrica 46
ES - Italia 39
BE - Belgio 35
PK - Pakistan 32
IR - Iran 25
PY - Paraguay 24
AU - Australia 23
CO - Colombia 23
PE - Perù 19
VE - Venezuela 19
UZ - Uzbekistan 18
MA - Marocco 17
EG - Egitto 15
AZ - Azerbaigian 13
CZ - Repubblica Ceca 13
CL - Cile 12
DO - Repubblica Dominicana 12
DZ - Algeria 11
KZ - Kazakistan 11
MY - Malesia 11
UY - Uruguay 11
KE - Kenya 9
LT - Lituania 9
BO - Bolivia 8
TN - Tunisia 8
AL - Albania 7
HN - Honduras 7
JO - Giordania 7
MK - Macedonia 7
TT - Trinidad e Tobago 7
CR - Costa Rica 6
ET - Etiopia 6
LK - Sri Lanka 6
NP - Nepal 6
RO - Romania 6
SA - Arabia Saudita 6
SN - Senegal 6
BG - Bulgaria 5
GE - Georgia 5
IL - Israele 5
JM - Giamaica 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
KG - Kirghizistan 4
NO - Norvegia 4
PA - Panama 4
AM - Armenia 3
CH - Svizzera 3
CY - Cipro 3
EU - Europa 3
GT - Guatemala 3
NG - Nigeria 3
OM - Oman 3
PS - Palestinian Territory 3
TH - Thailandia 3
TW - Taiwan 3
AO - Angola 2
BB - Barbados 2
CI - Costa d'Avorio 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NI - Nicaragua 2
PH - Filippine 2
SI - Slovenia 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BS - Bahamas 1
Totale 43.892
Salva come PNG Salva come JPEG
Città #
Moscow 5.267
Dublin 2.396
Jacksonville 1.913
Hong Kong 1.407
Santa Clara 1.252
Chandler 1.229
Singapore 1.197
Princeton 377
Roxbury 311
Seoul 307
Beijing 272
Naples 270
Ashburn 263
Hefei 247
Ann Arbor 223
Cambridge 220
Boardman 205
Ho Chi Minh City 169
Medford 168
New York 163
Wilmington 158
Dallas 157
Woodbridge 138
The Dalles 131
Bengaluru 117
São Paulo 107
Caserta 99
Hanoi 97
Munich 93
Des Moines 87
Rome 81
Houston 77
San Mateo 77
Mountain View 66
Los Angeles 65
Nanjing 63
Bremen 60
Dong Ket 54
Nuremberg 53
Milan 46
Vienna 43
Napoli 40
Düsseldorf 39
Belo Horizonte 38
Amsterdam 36
Rio de Janeiro 36
Jinan 33
Kraków 33
Aversa 31
Brasília 31
Brussels 31
Porto Alegre 31
Turku 31
Shanghai 30
Tianjin 30
Curitiba 28
Norwalk 28
Shenyang 28
Tokyo 28
Helsinki 26
Guangzhou 25
Potenza 25
Falkenstein 22
Auburn Hills 21
Guayaquil 21
Paris 21
Bologna 20
Council Bluffs 20
Haiphong 20
Johannesburg 20
Boydton 19
Da Nang 19
Campinas 18
Frankfurt am Main 18
Tashkent 18
Manaus 17
Salvador 17
San Francisco 17
Brooklyn 16
Chicago 16
London 16
Quito 16
Bari 15
Buenos Aires 15
Dhaka 15
Duhok 15
Nanchang 15
Changsha 14
Hangzhou 14
Palermo 14
Sennori 14
Thái Bình 14
Baku 13
Goiânia 13
Guarulhos 13
Jakarta 13
Mexico City 13
Warsaw 13
Atlanta 12
Groningen 12
Totale 21.002
Salva come PNG Salva come JPEG
Nome #
Sleisenger e Fordtran. Malattie gastrointestinali ed epatiche. Fisiopatologia, diagnosi e trattamento 335
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 196
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 196
Integrating Silybin and Sirtuin Related Pathways in Steatosis-Related Liver Diseases 182
Intrafamilial spread of Helicobacter pylori infection 181
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 177
Silybin for the treatment of metabolic oxidative alterations in patients with non-alcoholic steatohepatitis (NASH) 176
14-Day, High-Dose Acid Suppression, Non-Bismuth Quadruple Therapies (Hybrid vs. Concomitant) for Helicobacter pylori Infection: A Randomized Trial 165
Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo. 163
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 163
Alcohol and pathologies of the gastrointestinal tract, liver and pancreas 161
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 161
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life 161
Helicobacter pylory infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. 160
Autoimmune thyroid disease and neuroendocrine gastric tumors: early detection and efficacy of somatostatin analogue treatment. 160
Chronic inflammation and oxidative stress in human carcinogenesis 159
Crohn’s disease and skin 158
A pilot study on the ability of clinoptilolite to absorb ethanol in vivo in healthy drinkers: effect of gender 158
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 157
A case of hepatotoxicity caused by green tea 155
Composizione per il trattamento della sindrome metabolica e delle alterazioni metabolico-ossidative nei pazienti con steatoepatite non alcolica (NASH) 155
Alteration of haemostasis in non-metastatic gastric cancer 153
Long-term use of human albumin for the treatment of ascites in patients with hepatic cirrhosis: the interim analysis of the ANSWER study 152
A probiotic treatment ameliorates CCl4-induced liver fibrosis in rats. 152
A Facebook survey to obtain alcohol-related information by young people and adolescents. An Italian study 151
Alcoholic beverages and gastric epithelial cell viability: effect on oxidative stress-induced damage 151
Ameliorative effect of Silybin on bisphenol A induced oxidative stress, cell proliferation and steroid hormones oxidation in HepG2 cell cultures 151
Antioxidant effects of Silybin, Silybin-phosphatidylcholine complex, and derivatives of Silibinin on in vitro cultured cells damaged by oxidative stress 150
Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanism 147
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 146
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 145
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 145
Polydatin administration improves serum biochemical parameters and oxidative stress markers during chronic alcoholism: a pilot study 144
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study 144
Activated protein C resistance in nonmetastatic gastric cancer patients. 143
Attività citotossica della silibina su linee cellulari tumorali umane del tratto gastro-intestinale. 143
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 142
AISF position paper on liver disease and pregnancy 142
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments 141
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 141
Oral microbiota and salivary levels of oral pathogens in gastro‐intestinal diseases: Current knowledge and exploratory study 139
'' Non alcoholic fatty liver disease and eNOS dysfunction in humans '' 138
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 137
Aggregazione piastrinica in pazienti con epatite cronica da HCV: studi in vitro. 137
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 137
Amelanotic metastatic melanoma of the stomach presenting with iron deficiency anemia 137
Comparsa di pancreatite acuta ed epatite autoimmune in corso di trattamento con IFN: descrizione di un caso clinico. 136
A real-life study of new antiviral therapies in a high prevalence geographical area for hepatitis C virus infection 136
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 136
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 134
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 134
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab 134
Hericium erinaceus, a medicinal fungus with a centuries-old history: Evidence in gastrointestinal diseases 133
BNT162b2 mRNA COVID-19 vaccine is safe in a setting of patients on biologic therapy with inflammatory bowel diseases: a monocentric real-life study 133
Skin Adverse Events During Dual And Triple Therapy For HCV-Related Cirrhosis 133
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort 133
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study 132
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 131
Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota 131
Targeting the gut-brain axis for therapeutic adherence in patients with inflammatory bowel disease: a review on the role of psychotherapy 130
Evaluation of the Efficacy and Safety of a Compound of Micronized Flavonoids in Combination With Vitamin C and Extracts of Centella asiatica, Vaccinium myrtillus, and Vitis vinifera for the Reduction of Hemorrhoidal Symptoms in Patients With Grade II and III Hemorrhoidal Disease: A Retrospective Real-Life Study 130
Anorectal Function with High-Resolution Anorectal Manometry in Active Ulcerative Colitis and after Remission: A Pilot Study 129
A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations 129
Qualitative and quantitative evaluation of gut microbial populations in severely obese patients following bilio-intestinal bypass 129
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 129
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 129
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 127
Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis 127
A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer 126
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 126
Angiografia perfusionale con mdc di 2a generazione nella valutazione della efficacia necrotica delle terapie ablative percutanee (PAT): studio prospettico vs TC spirale. 126
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 126
An Italian survey on dietary habits and changes during the COVID-19 lockdown 126
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 126
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 124
Alcohol abuse affects nitric oxide production in patients with chronic liver disease. 124
Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF) 124
How immunotherapy has changed the continuum of care in hepatocellular carcinoma 124
Light alcohol drinking and the risk of cancer development: a controversial relationship 123
The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review 122
Vedolizumab as Rescue Therapy in Carboplatin-Gemcitabine-Induced Triggered Acute Severe Ulcerative Colitis Flare-Up 122
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer 122
Hericium erinaceus, in combination with natural flavonoid/alkaloid and B3/B8 vitamins, can improve inflammatory burden in Inflammatory bowel diseases tissue: an ex vivo study 121
Trace elements and chronic liver diseases 121
Obesità androide postmenopausale: ruolo del DHEA-S, didrotestosterone libero ed SHBG. 119
Cause di malnutrizione nel paziente neoplastico 118
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 118
Hashimoto’s thyroiditis and entero-chromaffin-like cell hyperplasia: early detection and somatostatin analogue treatment. 116
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 116
Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications 115
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 115
Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: a single-center retrospective study 115
The Role of Stress in Inflammatory Bowel Diseases 115
Environmental bisphenol A exposure triggers trained immunity-related pathways in monocytes 114
Considering a Janus kinase inhibitor in patients with concomitant ulcerative colitis and hidradenitis suppurativa/acne inversa: is it really a gamble? Hints from a case report 114
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 114
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials 113
Are Small Molecules Effective in Treating Inflammatory Pouch Disorders Following Ileal Pouch-Anal Anastomosis for Ulcerative Colitis? Here Is Where We Stand 113
Telaprevir- or boceprevir-based triple-therapy in patients with HCV infection genotype 1: on-treatment efficacy and data on safety 113
L’utilizzo di farmaci anti-TNF nella Malattia di Crohn 113
Totale 14.006
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.947
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.685 0 0 0 0 0 32 391 315 38 387 363 159
2021/20222.232 94 20 27 67 782 32 54 60 88 63 204 741
2022/20234.576 446 120 49 373 453 373 17 304 2.223 44 81 93
2023/20242.091 155 69 78 151 684 169 55 58 35 68 204 365
2024/20256.365 52 78 147 232 1.045 578 728 548 766 1.333 482 376
2025/202621.375 875 1.152 1.403 1.357 2.090 14.498 0 0 0 0 0 0
Totale 44.453